Daiichi Sankyo Co Limited Sponsored Adr News, Daiichi Sankyo Co Limited Sponsored Adr Quote, DSNKY Quote

Daiichi Sankyo Co Limited Sponsored Adr (OP:DSNKY) Delayed: 30.43 -0.07 (0.23%)

Prev. Close

$30.50

Open

$30.50

52 Wk High

$26.24

52 Wk Low

$18.86

Day High

$31.00

Day Low

$30.38

P/E

N/A

EPS

$0.00

Volume

12,678

Friends, Peers and Foes (?): 4568:JP, AZN MRK (more...)

Apr 5, 2024 11:10 PM ENHERTU® Approved in the U.S. as First Tumor Agnostic HER2 Directed Therapy for Previously Treated Patients with Metastatic HER2 Positive Solid Tumors
Apr 3, 2024 08:04 AM Daiichi Sankyo and Merck (MRK) Announce REJOICE-Ovarian01 Phase 2/3 Trial of Raludotatug Deruxtecan Initiated in Patients with Platinum-Resistant Ovarian Cancer
Apr 3, 2024 08:00 AM REJOICE-Ovarian01 Phase 2/3 Trial of Raludotatug Deruxtecan Initiated in Patients with Platinum-Resistant Ovarian Cancer
Apr 2, 2024 02:00 AM Datopotamab Deruxtecan Biologics License Application Accepted in the U.S. for Patients with Previously Treated Metastatic HR Positive, HER2 Negative Breast Cancer
Mar 24, 2024 09:13 AM UBS Reiterates Buy Rating on Daiichi Sankyo Company, Limited (4568:JP) (DSNKY)
Mar 4, 2024 02:00 AM Two Datopotamab Deruxtecan Applications Validated in the EU for Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer or HR Positive, HER2 Negative Breast Cancer
Feb 25, 2024 06:53 AM Daiichi Sankyo Company, Limited (4568:JP) (DSNKY) PT Raised to JPY5,700 at Bernstein
Feb 22, 2024 12:30 AM Daiichi Sankyo Company, Limited (4568:JP) (DSNKY) PT Raised to JPY5,600 at Jefferies
Feb 21, 2024 12:22 AM Daiichi Sankyo Company, Limited (4568:JP) (DSNKY) PT Raised to JPY5,800 at Macquarie
Feb 19, 2024 10:00 AM JPMorgan Reiterates Overweight Rating on Daiichi Sankyo Company, Limited (4568:JP) (DSNKY)

Entities mentioned with DSNKY